In the present review, two studies investigating TFPI2 methylation in stool and corresponding tissues found methylation of TFPI2 in CRC tissues in 89% and 99% of the samples, respectively, and the sensitivity in stool was 80% and 76%, respectively [33, 43]. This evidence concerns the gene TFPI2 and colorectal carcinoma.